학술논문
A randomized phase II/III trial of 3 weekly intraperitoneal versus intravenous carboplatin in combination with intravenous weekly dose-dense paclitaxel for newly diagnosed ovarian, fallopian tube and primary peritoneal cancer
Document Type
Article
Author
Source
In: Japanese Journal of Clinical Oncology . (Japanese Journal of Clinical Oncology, February 2011, 41(2):278-282)
Subject
Language
English
ISSN
03682811
14653621
14653621